Drug Diversion Prevention Isn’t a Technology Problem—It’s an Accountability Problem
Most health systems don’t have a drug diversion technology gap.
They have an execution gap.
Despite increased investment in monitoring tools and analytics, diversion events continue to occur—not because organizations lack data, but because they struggle to operationalize it. Alerts are generated, dashboards are reviewed, and yet risk persists in the spaces between people, process, and accountability.
The uncomfortable truth: many diversion programs are built to satisfy requirements, not to actively manage risk.
Too often, programs take shape only after an incident forces action—triggered by regulatory scrutiny, internal investigation, or financial penalty. At that point, organizations move quickly to implement software, establish committees, and document policies. But speed rarely translates to effectiveness. Without a clear operating model, these efforts become fragmented and difficult to sustain.
High-performing organizations take a fundamentally different approach. They treat diversion prevention as an operational discipline—not a compliance exercise.
That starts with visibility into real-world practice. Policies may define how controlled substances should move through a system, but frontline workflows often tell a different story. Without direct observation and validation, hidden variation persists—and with it, opportunity for diversion.
It also requires clarity in ownership. In many organizations, responsibility for diversion is shared across pharmacy, nursing, compliance, and security. But when ownership is diffuse, accountability is diluted. Effective programs establish clear roles, escalation pathways, and decision rights—ensuring that when risk is identified, action follows.
Technology plays an important role—but it is not the solution. Monitoring platforms can surface anomalies, but they cannot interpret context, assess intent, or make decisions. That work still depends on experienced professionals who can connect signals to reality and act with confidence.
The organizations making meaningful progress are those that integrate all three elements:
- People who are empowered and accountable
- Processes that are standardized, visible, and enforced
- Technology that enhances—not replaces—human judgment
As regulatory expectations continue to rise, the cost of getting this wrong is increasing. But the real risk isn’t just financial or reputational—it’s operational. Weak diversion programs introduce friction, erode trust, and ultimately compromise patient safety.
The path forward isn’t more tools.
It’s better alignment.